Haemophilus influenzae
type B, or Hib, disease is caused by a bacterial infection. It usually strikes children under five years old. Hib disease can lead to
meningitis,
pneumonia, swelling in the throat, infections, and even death.
People can carry Hib disease bacteria and not know it. These germs can spread from person to person, usually through respiratory droplets from an infected person. When the germs stay in the nose and throat, sickness will probably not occur. But when they spread into the lungs or the bloodstream, they can cause serious problems.
Before the Hib vaccine, severe Hib disease affected about 20,000 children in the United States under five years old, and nearly 1,000 people died each year.
Symptoms include:
- Fever
- Lethargy
- Vomiting
- Stiff neck
- Other symptoms, depending on the part of the body affected
It usually takes less than 10 days after being exposed to Hib disease to develop symptoms.
Hib disease is treated with antibiotics.
The Hib vaccine is made from inactivated elements of the bacteria. It is given by injection into the muscle and should be stored in a refrigerator prior to administration.
Children should get 3-4 doses of the Hib vaccine, at two, four, six, and 12-15 months of age. Depending on what brand of Hib vaccine they receive, children may or may not need the vaccine at six months. Children who miss a dose or get behind on schedule should get the next dose as soon as possible.
Sometimes children over five years old or adults with special health conditions should get the Hib vaccine. These include older children and adults with
sickle cell disease,
HIV/AIDS, removal of the spleen,
bone marrow transplant, or
cancer
treatment with drugs.
On December 13, 2007, Merck announced a voluntary recall of its Hib vaccine due to possible contamination, although no infections have been reported. Because of this recall, the US Centers for Disease Control and Prevention (CDC) is now recommending that parents delay getting their children the standard type B (Hib) vaccine booster at age 12-15 months. The shortage is expected to last into 2008. The initial three doses, though, should be given. Additionally, children at high risk for the disease should continue to receive the booster dose.*
Like any vaccine, the Hib vaccine is capable of causing serious problems, such as a severe allergic reaction. While most people do not have any problems with the Hib vaccine, some people experience mild problems, such as redness, warmth, or swelling near the injection site, or fever over 101˚F.
Most children over the age of five years old don’t need to get the Hib vaccine.
Anyone who has ever had a life-threatening allergic reaction to a previous dose of Hib vaccine should not get another dose. Children younger than six weeks should not get the Hib vaccine. And people who are moderately or severely ill should wait until they recover to get vaccinated.
Unvaccinated infants and young children who are exposed to a child with Hib disease may be given an antibiotic to prevent the spread of Hib disease.
In the event of a Hib disease outbreak, public health officials will determine the population(s) at risk of developing the infection and vaccinate all eligible people with the Hib vaccine.